Could 2 days of antibiotics be enough for deadly Flesh-Eating infections?

NCT ID NCT06002607

Recruiting now Disease control Sponsor: University of California, Irvine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a 48-hour course of antibiotics to a standard 7-day course for people with severe, life-threatening skin infections called necrotizing soft tissue infections. Researchers want to see if the shorter treatment is just as safe and effective. The trial will enroll 50 adults in the emergency department and track complications and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Antibiotics (Clindamycin, Vancomycin, Piperacillin Tazobactam)
What this could lead to: If successful, this could show that a shorter antibiotic course is safe for patients with severe skin infections, potentially reducing side effects and hospital stays.
What could go wrong: This is a small pilot study with only 50 participants, so results may not apply to everyone. The shorter course might not control the infection as well, leading to higher complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NECROTIZING SOFT TISSUE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

necrotizing soft tissue infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NECROTIZING SOFT TISSUE INFECTION

Contacts and locations

Locations

University of California Irvine Medical Center
RECRUITING

Orange, California, 92868, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.